Symbicort [clinicaltrials_resource:4872caa847c2fdf5c94cb04d57d4de6a]
Effect of Symbicort on GR Localisation in Asthma [clinicaltrials:NCT00159263]A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients [clinicaltrials:NCT00206154]A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD [clinicaltrials:NCT00206167]Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting [clinicaltrials:NCT00235911]SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults [clinicaltrials:NCT00238784]Budesonide / Formoterol in Treatment of Exacerbations of COPD [clinicaltrials:NCT00239278]MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults [clinicaltrials:NCT00242411]Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg [clinicaltrials:NCT00242775]A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler® [clinicaltrials:NCT00244608]Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients [clinicaltrials:NCT00252785]STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma [clinicaltrials:NCT00252824]DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults [clinicaltrials:NCT00252863]Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma [clinicaltrials:NCT00255255]SHARE - Symbicort and Health Economics in a Real Life Evaluation [clinicaltrials:NCT00259766]Comparison Between Symbicort® and Prednisolone in COPD [clinicaltrials:NCT00259779]SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults [clinicaltrials:NCT00259792]Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations [clinicaltrials:NCT00272753]SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma [clinicaltrials:NCT00288379]SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma [clinicaltrials:NCT00290264]Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy [clinicaltrials:NCT00319306]Prevention of Asthma Relapse After Discharge From Emergency [clinicaltrials:NCT00326053]Airway Clearance Study [clinicaltrials:NCT00379028]Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults [clinicaltrials:NCT00385593]Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) [clinicaltrials:NCT00413387]A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD [clinicaltrials:NCT00419744]clinicaltrials:NCT00419757clinicaltrials:NCT00419952Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD [clinicaltrials:NCT00421122]A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects [clinicaltrials:NCT00449501]A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects [clinicaltrials:NCT00449527]Local Phase 4 Pan-European SMART Study [clinicaltrials:NCT00463866]clinicaltrials:NCT00489853clinicaltrials:NCT00496470A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART [clinicaltrials:NCT00503061]A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice [clinicaltrials:NCT00505388]Symbicort SMART (Symbicort Maintenance And Reliever Therapy) [clinicaltrials:NCT00523679]A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler® [clinicaltrials:NCT00532922]clinicaltrials:NCT00536731clinicaltrials:NCT00536913clinicaltrials:NCT00542880
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Symbicort [clinicaltrials_resource:4872caa847c2fdf5c94cb04d57d4de6a]
Bio2RDF identifier
4872caa847c2fdf5c94cb04d57d4de6a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4872caa847c2fdf5c94cb04d57d4de6a
identifier
clinicaltrials_resource:4872caa847c2fdf5c94cb04d57d4de6a
title
Symbicort
@en
type
label
Symbicort [clinicaltrials_resource:4872caa847c2fdf5c94cb04d57d4de6a]
@en